---
title: "Pluri swaps 976,139 shares held by director's company for pre-funded warrants"
url: "https://aibio.space/news/pluri-swaps-976-139-shares-held-directors-company-pre-funded-warrants/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-04-25"
section: "Financings"
tickers: "NASDAQ:PLUR"
source: "https://www.sec.gov/Archives/edgar/data/1158780/000121390025035668/ea0239604-8k_pluri.htm"
summary: "The investor is a company wholly beneficially owned by director Alejandro Weinstein. The new warrants can be exercised only after shareholder approvals req"
---

By the aibio.space news desk.

Sources

- [Pluri Inc. 8-K (2025-04-25)](https://www.sec.gov/Archives/edgar/data/1158780/000121390025035668/ea0239604-8k_pluri.htm)

[PLUR](https://aibio.space/companies/pluri/)

2025-04-25

# Pluri swaps 976,139 shares held by director's company for pre-funded warrants

Tickers [PLUR](https://aibio.space/companies/pluri/)

The investor is a company wholly beneficially owned by director Alejandro Weinstein. The new warrants can be exercised only after shareholder approvals required by Nasdaq rules.

## Key facts

- **Company**: Pluri Inc. (NASDAQ: PLUR)

- **News type**: Financings

- **Primary source**: [Pluri Inc. 8-K (2025-04-25)](https://www.sec.gov/Archives/edgar/data/1158780/000121390025035668/ea0239604-8k_pluri.htm)

*An empty boardroom with a long table. CC0, via rawpixel. The picture shows the field, not the companies named.*

Pluri Inc. agreed on April 25, 2025 to exchange 976,139 of its common shares held by an investor for pre-funded warrants to buy the same number of shares.

The investor is a company wholly beneficially owned by Alejandro Weinstein, a non-U.S. investor and a director of Pluri, according to the [Form 8-K](https://www.sec.gov/Archives/edgar/data/1158780/000121390025035668/ea0239604-8k_pluri.htm). The exchange was made through an amendment to an earlier securities purchase agreement.

Under that agreement, Pluri had issued the investor 1,383,948 common shares, pre-funded warrants for up to 26,030 shares and warrants for up to 84,599 shares.

A pre-funded warrant is a right to receive shares for a nominal exercise price, here $0.0001 per share. The new warrants have the same terms as the earlier ones. They can be exercised only after Pluri receives certain shareholder approvals required by the rules of the Nasdaq Capital Market, and they remain exercisable until used in full. Until shareholder approval is obtained, they are subject to a 19.99% beneficial ownership limit. The warrants also carry customary anti-dilution provisions.

Pluri said the securities are exempt from registration under Section 3(a)(9) of the Securities Act of 1933. They have not been registered under that act.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

PLUR

Pluri Inc.

NASDAQ · Israel

Open the starter desk

## More in Financings

Financings

### [INmune Bio raises $4.50 million in registered direct offering with warrants](https://aibio.space/news/inmune-bio-raises-4-50-million-registered-direct-offering-warrants/)

Oct 29, 2026

Financings

### [Lexeo Therapeutics files $300 million shelf registration](https://aibio.space/news/lexeo-therapeutics-files-300-million-shelf-registration/)

Oct 29, 2026

Financings

### [ProKidney files $650 million shelf with $200 million Jefferies sales program](https://aibio.space/news/prokidney-files-650-million-shelf-200-million-jefferies-sales-program/)

Oct 29, 2026

---
Source page: https://aibio.space/news/pluri-swaps-976-139-shares-held-directors-company-pre-funded-warrants/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Pluri swaps 976,139 shares held by director's company for pre-funded warrants", 2025-04-25, https://aibio.space/news/pluri-swaps-976-139-shares-held-directors-company-pre-funded-warrants/